Filing Details

Accession Number:
0000915913-22-000143
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-09-07 16:43:05
Reporting Period:
2022-08-31
Accepted Time:
2022-09-07 16:43:05
Original Submission Date:
2022-09-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
915913 Albemarle Corp ALB Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) 541692118
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1776484 Goszcz Raphael Crawford Albemarle Corporation
4250 Congress Street, Suite 900
Charlotte NC 28209
President, Catalysts No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-31 7,218 $91.00 25,914 No 4 M Direct
Common Stock Disposition 2022-08-31 7,218 $268.28 18,696 No 4 S Direct
Common Stock Disposition 2022-08-31 320 $271.24 18,376 No 4 S Direct
Common Stock Disposition 2022-08-31 2,839 $271.59 15,537 No 4 S Direct
Common Stock Disposition 2022-08-31 7,591 $270.20 7,946 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-08-31 7,218 $0.00 7,218 $91.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-02-26 2029-02-25 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.05 to $269.65, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. See remark below.
  3. On February 26, 2019, the reporting person was granted a 10-year option exercisable for 7,218 shares of Common Stock. The option cliff-vested on 2/26/2022.